Status:
UNKNOWN
A Prospective Study to Assess the Utility of CA-4F in a Canadian Cardiology Setting
Lead Sponsor:
Ensho Health Intelligent Systems Inc.
Conditions:
Transthyretin Amyloid Cardiomyopathy ("ATTR-CM")
Eligibility:
All Genders
30+ years
Phase:
NA
Brief Summary
This study will assess whether CA-4F can improve diagnosis of ATTR-CM in a community cardiology setting when used to screen electronic medical record data for patients suitable for follow-up investiga...
Detailed Description
This is a prospective multicentre observational study to assess whether CA-4F can improve diagnosis of ATTR-CM in a community cardiology setting when used to screen electronic medical record data for ...
Eligibility Criteria
Inclusion
- Licensed cardiologist in the Canadian provinces of Ontario, Saskatchewan or British Columbia
- Outpatient cardiology practice with ≥1,200 unique patients annually
- Have used an electronic medical record system for ≥36 months from enrollment
- Currently subscribed to the Advanced Computing Platform by Ensho Health or using a cloud-hosted electronic medical record system compatible with the Apollo Electronic Data Capture System
- Experience with the clinical management of ATTR-CM
- Access to PYP scanning for follow-up investigations
- Previous participation in clinical studies
Exclusion
- Predominantly hospital-based cardiology practice
- Have used an electronic medical record system for \<36 months from enrollment
- Electronic medical record system incompatible with the Apollo Electronic Data Capture system
- No prior experience with the clinical management of ATTR-CM
- No access to PYP scanning for follow-on investigations
- No prior participation in clinical studies
Key Trial Info
Start Date :
November 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 31 2022
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT05210010
Start Date
November 1 2021
End Date
May 31 2022
Last Update
January 27 2022
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Site 85237
North Vancouver, British Columbia, Canada
2
Site 26174
Oakville, Ontario, Canada
3
Site 47844
Scarborough Village, Ontario, Canada